Sort
50,496 grants matching “lung cancer”
Metabolic activation of nitroarenes and Nrf2-Keap1
$468,766Trevor M. Penning · University Of Pennsylvania · R01 · FY2021 · ES
Etiologic Studies of Diet and Cancer
$468,706Neal Freedman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Project 2: Delta Stromal Ecology of NSCLC
$468,705Andriy Marusyk · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2025 · CA
Biosynthesis of Tracheal Mucous Glycoproteins
$468,688Pi-Wan Cheng · University Of Nebraska Medical Center · R01 · FY2009 · HL
TARGETING METABOLIC SURVIVAL PATHWAYS IN LUNG CANCER VIA COMBINATION THERAPY
$468,667University Of California, San Diego · · FY2013 · Department of Defense
Statistical methods for genomic analysis of heterogeneous tumors
$468,663Wenyi Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
$468,512Jiyoung Ahn · New York University School Of Medicine · R01 · FY2017 · CA
GENETICS OF TOBACCO AND ALCOHOL RELATED CANCERS
$468,509Paul Joseph Brennan · International Agency For Res On Cancer · R01 · FY2007 · CA
Unraveling mechanisms of tumor suppression in lung cancer
$468,496Monte Meier Winslow · Stanford University · R01 · FY2022 · CA
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer
$468,495Jacob Gardinier Scott · Cleveland Clinic Lerner Com-Cwru · R37 · FY2020 · CA
Assessment of a Teachable Moment for Smoking Cessation
$468,487Robert A Schnoll · University Of Pennsylvania · R01 · FY2008 · CA
Integrative genomic analysis of the human response to glucocorticoids
$468,427Luis M Franco · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Genetic dissection of oncogenic RAS-driven tumor initiation in vivo
$468,413Christopher M Counter · Duke University · R01 · FY2023 · CA
Training in Comparative Lung Biology and Medicine
$468,403Nicholas J Kenyon · University Of California At Davis · T32 · FY2019 · HL
PI3K Beta regulation of tumor metastasis
$468,302Anne R Bresnick · Albert Einstein College Of Medicine · P01 · FY2025 · CA
Anticancer Agent Pharmacodynamics in Acute Leukemia
$468,296St. Jude Children'S Research Hospital · R01 · FY2003 · CA
Social Determinants of Health Research Project
$468,281Ashley Housten · Washington University · U19 · FY2025 · CA
Targeting UHRF1 in combinational immunotherapy
$468,277Xiao-Fan Wang · Duke University · R01 · FY2021 · CA
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCE
$468,259Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2022 · CA
Genetic dissection of oncogenic Kras signaling
$468,244Monte Meier Winslow · Stanford University · R01 · FY2021 · CA
Exosome secretion in breast cancer progression
$468,221Alissa M Weaver · Vanderbilt University · R01 · FY2021 · CA
Computer Support for Prostate Cancer Screening in the PLCO Cancer Screening Trial
$468,192William Lake · Information Management Services, Inc. · N02 · FY2010 · CA
Targeting UHRF1 in combinational immunotherapy
$468,148Xiao-Fan Wang · Duke University · R01 · FY2020 · CA
SOUTHWEST ONCOLOGY GROUP
$468,138Swedish Medical Center, First Hill · U10 · FY2003 · CA
Identifying metabolic dependencies in genetic subtypes of KRAS-driven lung cancer
$468,120Thales Papagiannakopoulos · New York University School Of Medicine · R37 · FY2018 · CA